MoonLake Immunotherapeutics
MLTX
MLTX
24 hedge funds and large institutions have $291M invested in MoonLake Immunotherapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Holders
24
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.37M | |
| 2 | +$2.12M | |
| 3 | +$706K | |
| 4 |
JG
Jefferies Group
New York
|
+$478K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$424K |
Top Sellers
| 1 | -$2.64M | |
| 2 | -$424K | |
| 3 | -$147K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$118K |
| 5 |
CAC
Cowen and Company
New York
|
-$85K |